Original Article

The Effect of Preoperative 25-Hydroxy Vitamin D Supplement and Surgical Site Infection

Abstract

Surgical site infection (SSI) is one of the most important complications of surgery and is known in quality improvement programs as a very important indicator for evaluating the performance of surgeons and hospitals. In recent studies, interesting effects for vitamin D such as antimicrobial effects, wound healing, immune regulation, etc. have been considered and the effectiveness of this vitamin on the above has been proven in laboratory environments and animal models. Therefore, the present study was designed and performed to evaluate the effect of vitamin D tablets before surgery on surgical site infection in patients referred to Shariati Hospital. This study was performed as a randomized controlled trial (RCT) on 200 patients who underwent surgery in Shariati Hospital in Tehran and in the general surgery department between 1397 and 1398. Patients were randomly assigned to two groups of 100 persons, including intervention and control. In all patients, vitamin D levels were measured and recorded 15 days before surgery. The intervention group included patients who received 2 tablets of fifty thousand units of vitamin D seven to ten days before the operation. The second group also included patients who did not undergo any intervention and only in order to maintain blindness of the same size and simultaneously with the first group. They received a placebo. Finally, all patients were followed at intervals of one, three, seven and thirty days after surgery and then compared to the extent of infection at the site of surgery and other desired variables. In this study, 200 persons with a mean age of 47.78 years were examined. 57.5% (115 persons) were female and the rest were male. Overall, 19 (9.5%) of the patients studied underwent surgery at the site of follow-up within one month of follow-up (14 in the control group and 5 in the intervention group). Detection between the two groups was observed in terms of infection (P=0.030). In general, based on the results of the analysis, in the present study, there was a statistically significant relationship between surgical site infection with low serum vitamin D level, increase in the number of hospital days, female gender, wound classification, ASA class of patients and vitamin D consumption before surgery. (P<0.05). The results of this study showed that there is a significant relationship between surgical site infection and consumption of edible vitamin D as well as serum vitamin D levels before surgery so that vitamin D deficiency can be considered as an independent risk factor for infection. Hospitals were considered, including surgical site infections. Therefore, performing preoperative tests as well as performing the required interventions can be very effective in improving this index and reducing surgical site infections.

1. Lawson EH, Hall B, Ko CY. Risk factors for superficial vs deep/organ-space surgical site infections: Implications for quality improvement initiatives. JAMA Surg 2013;148:849-58.
2. Berenguer CM, Ochsner MG Jr, Lord SA, Senkowski CK. Improving surgical site infections: using National Surgical Quality Improvement Program data to institute Surgical Care Improvement Project protocols in improving surgical outcomes. J Am Coll Surg 2010;210:737-41.
3. Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect 2008;70:3-10.
4. Zubair M, Malik A, Meerza D, Ahmad J. 25-Hydroxyvitamin D [25(OH)D] levels and diabetic foot ulcer: Is there any relationship? Diabetes Metab Syndr 2013;7:148-53.
5. Burkiewicz CJ, Guadagnin FA, Skare TL, Nascimento MM, Servin SCN, Souza GD. Vitamina D e cicatrização de pele: estudo prospectivo, duplo-cego, placebo controlado na cicatrização de úlceras de perna. Rev Col Bras Cir 39:401-7.
6. Mostafa WZ, Hegazy RA. Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res 2015;6:793-804.
7. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011;55:96-108.
8. Heilborn JD, Weber G, Grönberg A, Dieterich C, Ståhle M. Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo. Exp Dermatol 2010;19:332-8.
9. Oda Y, Tu CL, Menendez A, Nguyen T, Bikle DD. Vitamin D and calcium regulation of epidermal wound healing. J Steroid Biochem Mol Biol 2016;164:379-85.
10. Molinari C, Rizzi M, Squarzanti DF, Pittarella P, Vacca G, Reno F. 1alpha,25-Dihydroxycholecalciferol (Vitamin D3) induces NO-dependent endothelial cell proliferation and migration in a three-dimensional matrix. Cell Physiol Biochem 2013;31:815-22.
11. Youssef DA, Ranasinghe T, Grant WB, Peiris AN. Vitamin D's potential to reduce the risk of hospital-acquired infections. Dermatoendocrinol 2012;4:167-75.
12. Quraishi SA, Bittner EA, Blum L, Hutter MM, Camargo CA Jr. Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgery. JAMA Surg 2014;149:112-8.
13. Alipour S, Saberi A, Seifollahi A, Shirzad N, Hosseini L. Risk factors and prevalence of vitamin d deficiency among Iranian women attending two university hospitals. Iran Red Crescent Med J 2014;16:e15461.
14. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 2004;4:38.
15. Rahnavard Z, Eybpoosh S, Homami MR, Meybodi HA, Azemati B, Heshmat R, et al. Vitamin d deficiency in healthy male population: results of the Iranian multi- center osteoporosis study. Iran J Public Health 2010;39:45-52.
16. ACS, American college of surgeons. User Guide for the 2012. ACS NSQIP Participant Use Data File; 2013.
17. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
18. Ghorbani Abdehgah A, Monshizadeh A, Mohajeri Tehrani M, Afhami S, Molavi B, Jafari M, et al. Relationship Between Preoperative 25-Hydroxy Vitamin D and Surgical Site Infection. J Surg Res 2020;245:338-43.
19. Askarian M, Rostami-Gooran N. National nosocomial infection surveillance system-based study in Iran: Additional hospital stay attributable to nosocomial infections. Am J Infect control 2003;31:465-8.
20. Poveda Vde B, Galvao CM, Hayashida M. Analysis of risk factors related to the incidence of surgical site infections in gastrosurgeries. Rev Esc Enferm USP 2003;37:81-9.
21. Olson M, O’connor M, Schwartz ML. Surgical wound Infections. A 5-year prospective study of ,193 wounds at the Minneapolis VA Medical center. Ann Surg 1984;199:253-9.
Files
IssueVol 61 No 1 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/acta.v61i1.12124
Keywords
Vitamin D tablets Surgical site infection Risk factors Surgical site infection (SSI)
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Sadeghian E, Yaghoobi Notas A, Eslamian R, Ghorbani Abdehgah A, Mohajeri Tehrani M. The Effect of Preoperative 25-Hydroxy Vitamin D Supplement and Surgical Site Infection. Acta Med Iran. 2023;61(1):36-42.